[Histonet] Invitation from Dr. Helen Moore, OBBR, NCI to attendFree BRN Sypmposium in March

From:"Dr. Andrea Kelly"



The National Cancer Institute (NCI) Office of Biorepositories and=20
Biospecimen Research (OBBR) and the National Institutes of Health Office 
of Rare Diseases announce the Biospecimen Research Network (BRN) Symposium:

 

*"/Advancing Cancer Research Through Biospecimen Science"/*

*March 13-14, 2008*

Renaissance M Street Hotel

1143 New Hampshire Avenue NW

Washington, D.C.

 

The primary goal of the symposium is to address the significant impact 
of pre-analytical biospecimen variability on cancer research and 
molecular medicine.

 

The symposium will feature expert presentations and interactive 
discussions on topics in biospecimen science including:

·         /HER2/neu/: Lessons Learned

·         Access to Existing Knowledge in Biospecimen Science

·         Research Advances in Biospecimen Science

·         Assessing and Qualifying Biospecimen Quality

·         Patient's Perspective on Biospecimen Quality

·         Incorporating Biospecimen Science Into Research and Clinical 
Practice

 

Key presenters to address the significant impact of biospecimen 
variability in cancer research and recent advances in biospecimen=20
science include:

·                     Patrick O. Brown, M.D., Ph.D., Stanford University 
School of Medicine

·                     Carolyn C. Compton, M.D., Ph.D., OBBR, NCI

·                     Angelo deMarzo, M.D., Ph.D., Johns Hopkins University

·                     Theo deVos, Ph.D., Epigenomics, Inc. 

·                     Steve Gutman, M.D., M.B.A., Food and Drug=20
Administration

·                     Elizabeth Hammond, M.D., FCAP, University of=20
Utah/LDS Hospital Daniel Hayes, M.D., University of Michigan

·                     Scott Jewell, Ph.D., Ohio State University

·                     Paula Kim, Translating Research Across Communities

·                     Lance Liotta, M.D, Ph.D., George Mason University

·                     Chris Logothetis, M.D., M.D. Anderson Cancer Center

·                     Scott D. Patterson, Ph.D., Amgen Inc.

·                     David Ransohoff, M.D., University of North=20
Carolina at Chapel Hill

·                     Gerry Thomas, Ph.D. Imperial College London,=20
United Kingdom

·                     Paul Waring, Ph.D., Genentech, Inc.

·                     and others

 

This interactive symposium is free and open to the public and is 
expected to be of particular value to research investigators, 
clinicians, government representatives, industry representatives, and=20
patient advocates. *For more information, to register, and to submit an 
abstract, please visit www.brnsymposium.com .*

* *

We apologize if you receive more than one copy of this notice. Please=20
share this notice with any interested colleagues. We look forward to=20
your participation. If you have any questions about the meeting or=20
registration, please contact Marlene Goldman at 
mgoldman@md.capconcorp.com or 301-468-6004 ext. 416.

 

 

Sincerely,

 

Helen M. Moore, Ph.D.

Biospecimen Research Network Program Manager

Office of Biorepositories and Biospecimen Research

Office of the Director

National Cancer Institute

31 Center Drive, 31/10A03

Bethesda, MD 20892-2590

Phone:  (301) 496-1550

Fax:  (301) 480-4814

E-mail:  moorehe@mail.nih.gov 

http://biospecimens.cancer.gov 

-- 

Posted by
Andrea Kelly, Ph.D.

Rose Li & Associates
Contractor to NCI, OBBR


 


_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet




<< Previous Message | Next Message >>